A novel gene expression system for detecting viable bladder cancer cells

International Journal of Oncology

Volumn 41, Issue 1, 2012, Pages 135-140

  Ueki, Hideo ^a   Watanabe, Masami ^a   Kaku, Haruki ^a   Huang, Peng ^a   Li, Shun Ai ^a   Ochiai, Kazuhiko ^a   Hirata, Takeshi ^a   Noguchi, Hirofumi ^b   Yamada, Hiroshi ^b   Takei, Kohji ^b   Nasu, Yasutomo ^a   Kashiwakura, Yuji ^a   Kumon, Hiromi ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

Author keywords

Bladder cancer; Green fluorescent protein; Human telomerase reverse transcriptase; Plasmid; Two step transcriptional amplification

Indexed keywords

COMPLEMENTARY DNA; GLUCOCORTICOID RECEPTOR; GREEN FLUORESCENT PROTEIN; HYBRID PROTEIN; LUCIFERASE; PLASMID VECTOR; POLYGLUTAMINE; TELOMERASE; TELOMERASE REVERSE TRANSCRIPTASE; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR GAL4;

AMINO ACID SEQUENCE; ARTICLE; BLADDER CANCER; CANCER CELL; ENZYME ACTIVITY; ENZYME ASSAY; GENE AMPLIFICATION; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; TISSUE SPECIFICITY; TWO STEP TRANSCRIPTIONAL AMPLIFICATION;

CELL LINE, TUMOR; GENES, REPORTER; GREEN FLUORESCENT PROTEINS; HUMANS; LUCIFERASES; PROMOTER REGIONS, GENETIC; RECOMBINANT PROTEINS; TELOMERASE; TRANSCRIPTION, GENETIC; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

EID: 84862875342     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2012.1417     Document Type: Article

References (14)

1. Kirkali Z, Chan T, Manoharan M, Algaba F, Busch C, Cheng L, Kiemeney L, Kriegmair M, Montironi R, Murphy WM, Sesterhenn IA, Tachibana M and Weider J: Bladder cancer: epidemiology, staging and grading, and diagnosis. Urology 66: 4-34, 2005. (Pubitemid 43049607)
2. Takakura M, Kyo S, Kanaya T, Hirano H, Takeda J, Yutsudo M and Inoue M: Cloning of human telomerase catalytic subunit (hTERT) gene promoter and identification of proximal core promoter sequences essential for transcriptional activation in immortalized and cancer cells. Cancer Res 59: 551-557, 1999. (Pubitemid 29076049)
3. Kishimoto H, Kojima T, Watanabe Y, Kagawa S, Fujiwara T, Uno F, Teraishi F, Kyo S, Mizuguchi H, Hashimoto Y, Urata Y, Tanaka N and Fujiwara T: In vivo imaging of lymph node metastasis with telomerase-specific replication-selective adenovirus. Nat Med 12: 1213-1219, 2006. (Pubitemid 44527360)
4. Maida Y, Kyo S, Sakaguchi J, Mizumoto Y, Hashimoto M, Mori N, Ikoma T, Nakamura M, Takakura M, Urata Y, Fujiwara T and Inoue M: Diagnostic potential and limitation of imaging cancer cells in cytological samples using telomerase-specific replicative adenovirus. Int J Oncol 34: 1549-1556, 2009.
5. Lin Y, Miyamoto H, Fujinami K, Uemura H, Hosaka M, Iwasaki Y and Kubota Y: Telomerase activity in human bladder cancer. Clin Cancer Res 2: 929-932, 1996. (Pubitemid 26198462)
6. Xie XY, Yang X, Zhang JH and Liu ZJ: Analysis of hTERT expression in exfoliated cells from patients with bladder transitional cell carcinomas using SYBR green real-time fluorescence quantitative PCR. Ann Clin Biochem 44: 523-528, 2007. (Pubitemid 351724635)
7. Huang P, Watanabe M, Kaku H, Kashiwakura Y, Chen J, Saika T, Nasu Y, Fujiwara T, Urata Y and Kumon H: Direct and distant antitumor effects of a telomerase-selective oncolytic adenoviral agent, OBP-301, in a mouse prostate cancer model. Cancer Gene Ther 15: 315-322, 2008. (Pubitemid 351508138)
8. Huang P, Kaku H, Chen J, Kashiwakura Y, Saika T, Nasu Y, Urata Y, Fujiwara T, Watanabe M and Kumon H: Potent antitumor effects of combined therapy with a telomerase-specific, replication-competent adenovirus (OBP-301) and IL-2 in a mouse model of renal cell carcinoma. Cancer Gene Ther 17: 484-491, 2010.
9. Watanabe M, Ueki H, Ochiai K, Huang P, Kobayashi Y, Nasu Y, Sasaki K, Kaku H, Kashiwakura Y and Kumon H: Advanced two-step transcriptional amplification as a novel method for cancer-specific gene expression and imaging. Oncol Rep 26: 769-775, 2011.
10. Sadowski I, Ma J, Triezenberg S and Ptashne M: GAL4-VP16 is an unusually potent transcriptional activator. Nature 335: 563-564, 1988.
11. Iyer M, Wu L, Carey M, Wang Y, Smallwood A and Gambhir SS: Two-step transcriptional amplification as a method for imaging reporter gene expression using weak promoters. Proc Natl Acad Sci USA 98: 14595-14600, 2001. (Pubitemid 33121437)
12. Gerber HP, Seipel K, Georgiev O, Höfferer M, Hug M, Rusconi S and Schaffner W: Transcriptional activation modulated by homopolymeric glutamine and proline stretches. Science 263: 808-811, 1994. (Pubitemid 24093208)
13. Zhang K, Watanabe M, Kashiwakura Y, Li SA, Edamura K, Huang P, Yamaguchi K, Nasu Y, Kobayashi Y, Sakaguchi M, Ochiai K, Yamada H, Takei K, Ueki H, Huh NH, Li M, Kaku H, Na Y and Kumon H: Expression pattern of REIC/Dkk-3 in various cell types and the implications of the soluble form in prostatic acinar development. Int J Oncol 37: 1495-1501, 2010.
14. Emami KH and Carey M: A synergistic increase in potency of a multimerized VP16 transcriptional activation domain. EMBO J 11: 5005-5012, 1992. (Pubitemid 23023444)